I agree with your very bullish outlook @Tarvold IMHO especially when you look at the range of products NXS already has in the market and the plethora of new products to come. I can see a time when NXS' products will be recognised Worldwide as the Gold standard for treating antibiotic resistant infections and that their products will become a household name like Betadine IMHO DYOR It may take some time, due to the medical profession's rightfully cautious approach to taking up new products but, over time, I believe NXS has significant potential in the long run.
Ann: Investor Presentation, page-11
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.005(2.13%) |
Mkt cap ! $70.11M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.3¢ | $3.257K | 13.57K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6601 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 145820 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| NXS (ASX) Chart |